代谢疾病Empagliflozin, via Switching Metabolism Toward Lipid Utilization, Moderately Increases LDL Cholesterol Levels Through Reduced LDL Catabolism.
期刊:Diabetes发表年份:2016作者:François Briand; Eric Mayoux; Emmanuel Brousseau; Noémie Burr; Isabelle Urbain; Clément Costard; Michael Mark; Thierry Sulpice
